Breaking News

PharmaBlock Acquires cGMP Mfg. Facility

The 1,436,000ft2 (approximately 133,400m2) site was purchased from Porton Pharma Solutions Ltd

PharmaBlock Sciences has acquired a GMP compliant manufacturing facility in China from Porton Pharma Solutions Ltd.  The 1,436,000ft2 (approximately 133,400m2) site, located in a State-level chemical industry park in Shangyu, Zhejiang Province, has been operating as a multi-purpose GMP compliant facility since December 2015. Assets include reactors from 300L to 6300L, with more than 180m3 of combined reactor volume. The facility is well equipped to practice a wide range of chemistry synthesis...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters